Bloomberg Law

Latest Stories

Fate Therapeutics Leaders Misrepresented J&J Tie, Investor Says

Fate Therapeutics Inc.'s executives and directors harmed the drugmaker when they overstated the viability of its partnership with the Johnson & Johnson unit Janssen Biotech Inc. in public statements and filings, an investor says in a new derivative suit.